10, 2025 — Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded ...

Alzheimer's Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future ...

Feb. 4, 2025 — Scientists provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease. Their findings, ... Scientists Identify ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

New research suggests that Alzheimer’s disease damages the brain in two separate phases, with the first phase happening slowly and quietly before any symptoms appear, while the second phase ...

Su Jin Yim and colleagues argue that with the proposed definition of Alzheimer’s disease (AD) expanding in the most recent ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

More than 5 million people in the United States live with Alzheimer’s disease. Alzheimer’s disease is a brain disease that impacts your ability to think and remember. When it happens in ...

Whether you're curious to explore a healthy brain or brains affected by Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, or Frontotemporal dementia, the choice is yours. Tailoring ...

A new biomarker test developed at the University of Pittsburgh could help doctors doctors detect signs of Alzheimer's years sooner, according to research published Monday in Nature Medicine.